Supernus Pharmaceuticals | Omløpsmidler

Current Assets Endring Dato
Abbott USD 22.38B 1.13B 2024-03
ANI Pharmaceuticals USD 540.56M 20.74M 2024-03
Aurora Cannabis CAD 406.53M 18.55M 2023-12
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Canopy Growth CAD 371.18M 26.1M 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Eisai JPY 661B 1.73B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
Pacira USD 543.11M 33.12M 2024-03
Perrigo USD 2.81B 26.5M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Supernus Pharmaceuticals USD 544.32M 51.21M 2024-03
United Therapeutics USD 3.25B 302.3M 2024-03
Xeris Pharmaceuticals USD 173.28M 17.02M 2024-03



Supernus Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.